🇺🇸 FDA
Patent

US 10988763

Single-stranded RNA-editing oligonucleotides

granted A61KA61K31/7125A61P

Quick answer

US patent 10988763 (Single-stranded RNA-editing oligonucleotides) held by ProQR Therapeutics II B.V. expires Mon Apr 22 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
ProQR Therapeutics II B.V.
Grant date
Tue Apr 27 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 22 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/7125, A61P, A61P1/04, A61P11/00